Global Bio-pharma Market Research Report 2012-2024

July 2019 | 116 pages | ID: G39ACE29366EN
HeyReport

Abstracts

SUMMARY


The global Bio-pharma market will reach xxx Million USD in 2019 with CAGR xx% 2019-2024. The objective of report is to define, segment, and project the market on the basis of product type, application, and region, and to describe the content about the factors influencing market dynamics, policy, economic, technology and market entry etc.

Based on products type, the report describes major products type share of regional market. Products mentioned as follows:

• Monoclonal Antibodies
• Recombinant Proteins
• Granulocyte-Colony Stimulating Factor (G-CSF)
• Interferons
• Recombinant Human Insulin
• Erythropoietin
• Vaccines
• Growth Hormones
• Purified Proteins
• Others

Leading vendors in the market are included based on profile, business performance etc. Vendors mentioned as follows:

• Pfizer
• F. Hoffmann-La Roche AG
• Johnson & Johnson Services
• Sanofi, Amgen
• AbbVie
• Merck & Co.
• Biogen Idec
• Bayer AG
• Eli Lilly and Company
• Novartis AG GlaxoSmithKline Plc
• Bristol-Myers Squibb Company
• AstraZeneca PLC
• Abbott Laboratories

Based on Application, the report describes major application share of regional market. Application mentioned as follows:

• Metabolic Disorders
• Oncology
• Neurological Disorders
• Cardiovascular Diseases
• Inflammatory and Infectious Diseases
• Others

Based on region, the report describes major regions market by products and application. Regions mentioned as follows:

• Asia-Pacific
• North America
• Europe
• South America
• Middle East & Africa

Contents

1 MARKET OVERVIEW

1.1 Objectives of Research
  1.1.1 Definition
  1.1.2 Specifications
1.2 Market Segment
  1.2.1 by Type
    1.2.1.1 Monoclonal Antibodies
    1.2.1.2 Recombinant Proteins
    1.2.1.3 Granulocyte-Colony Stimulating Factor (G-CSF)
    1.2.1.4 Interferons
    1.2.1.5 Recombinant Human Insulin
    1.2.1.6 Erythropoietin
    1.2.1.7 Vaccines
    1.2.1.8 Growth Hormones
    1.2.1.9 Purified Proteins
    1.2.1.10 Others
  1.2.2 by Application
    1.2.2.1 Metabolic Disorders
    1.2.2.2 Oncology
    1.2.2.3 Neurological Disorders
    1.2.2.4 Cardiovascular Diseases
    1.2.2.5 Inflammatory and Infectious Diseases
    1.2.2.6 Others
  1.2.3 by Regions

2 INDUSTRY CHAIN

2.1 Industry Chain Structure
2.2 Upstream
2.3 Market
  2.3.1 SWOT
  2.3.2 Dynamics

3 ENVIRONMENTAL ANALYSIS

3.1 Policy
3.2 Economic
3.3 Technology
3.4 Market Entry

4 MARKET SEGMENTATION BY TYPE

4.1 Market Size
  4.1.1 Monoclonal Antibodies Market, 2013-2018
  4.1.2 Recombinant Proteins Market, 2013-2018
  4.1.3 Granulocyte-Colony Stimulating Factor (G-CSF) Market, 2013-2018
  4.1.4 Interferons Market, 2013-2018
  4.1.5 Recombinant Human Insulin Market, 2013-2018
  4.1.6 Erythropoietin Market, 2013-2018
  4.1.7 Vaccines Market, 2013-2018
  4.1.8 Growth Hormones Market, 2013-2018
  4.1.9 Purified Proteins Market, 2013-2018
  4.1.10 Others Market, 2013-2018
4.2 Market Forecast
  4.2.1 Monoclonal Antibodies Market Forecast, 2019-2024
  4.2.2 Recombinant Proteins Market Forecast, 2019-2024
  4.2.3 Granulocyte-Colony Stimulating Factor (G-CSF) Market Forecast, 2019-2024
  4.2.4 Interferons Market Forecast, 2019-2024
  4.2.5 Recombinant Human Insulin Market Forecast, 2019-2024
  4.2.6 Erythropoietin Market Forecast, 2019-2024
  4.2.7 Vaccines Market Forecast, 2019-2024
  4.2.8 Growth Hormones Market Forecast, 2019-2024
  4.2.9 Purified Proteins Market Forecast, 2019-2024
  4.2.10 Others Market Forecast, 2019-2024

5 MARKET SEGMENTATION BY APPLICATION

5.1 Market Size
  5.1.1 Metabolic Disorders Market, 2013-2018
  5.1.2 Oncology Market, 2013-2018
  5.1.3 Neurological Disorders Market, 2013-2018
  5.1.4 Cardiovascular Diseases Market, 2013-2018
  5.1.5 Inflammatory and Infectious Diseases Market, 2013-2018
  5.1.6 Others Market, 2013-2018
5.2 Market Forecast
  5.2.1 Metabolic Disorders Market Forecast, 2019-2024
  5.2.2 Oncology Market Forecast, 2019-2024
  5.2.3 Neurological Disorders Market Forecast, 2019-2024
  5.2.4 Cardiovascular Diseases Market Forecast, 2019-2024
  5.2.5 Inflammatory and Infectious Diseases Market Forecast, 2019-2024
  5.2.6 Others Market Forecast, 2019-2024

6 MARKET SEGMENTATION BY REGION

6.1 Market Size
  6.1.1 Asia-Pacific
    6.1.1.1 Asia-Pacific Market, 2012-2018
    6.1.1.2 Asia-Pacific Market by Type
    6.1.1.3 Asia-Pacific Market by Application
  6.1.2 North America
    6.1.2.1 North America Market, 2012-2018
    6.1.2.2 North America Market by Type
    6.1.2.3 North America Market by Application
  6.1.3 Europe
    6.1.3.1 Europe Market, 2012-2018
    6.1.3.2 Europe Market by Type
    6.1.3.3 Europe Market by Application
  6.1.4 South America
    6.1.4.1 South America Market, 2012-2018
    6.1.4.2 South America Market by Type
    6.1.4.3 South America Market by Application
  6.1.5 Middle East & Africa
    6.1.5.1 Middle East & Africa Market, 2012-2018
    6.1.5.2 Middle East & Africa Market by Type
    6.1.5.3 Middle East & Africa Market by Application
6.2 Market Forecast
  6.2.1 Asia-Pacific Market Forecast, 2019-2024
  6.2.2 North America Market Forecast, 2019-2024
  6.2.3 Europe Market Forecast, 2019-2024
  6.2.4 South America Market Forecast, 2019-2024
  6.2.5 Middle East & Africa Market Forecast, 2019-2024

7 MARKET COMPETITIVE

7.1 Global Market by Vendors
7.2 Market Concentration
7.3 Price & Factors
7.4 Marketing Channel

8 MAJOR VENDORS

8.1 Pfizer
8.2 F. Hoffmann-La Roche AG
8.3 Johnson & Johnson Services
8.4 Sanofi, Amgen
8.5 AbbVie
8.6 Merck & Co.
8.7 Biogen Idec
8.8 Bayer AG
8.9 Eli Lilly and Company
8.10 Novartis AG GlaxoSmithKline Plc
8.11 Bristol-Myers Squibb Company
8.12 AstraZeneca PLC
8.13 Abbott Laboratories

9 CONCLUSION

List Of Tables

LIST OF TABLES

Table Product Specifications of Bio-pharma
Table Products Segment of Bio-pharma
Table Monoclonal Antibodies Overview
Table Recombinant Proteins Overview
Table Granulocyte-Colony Stimulating Factor (G-CSF) Overview
Table Interferons Overview
Table Recombinant Human Insulin Overview
Table Erythropoietin Overview
Table Vaccines Overview
Table Growth Hormones Overview
Table Purified Proteins Overview
Table Others Overview
Table Global Bio-pharma Market by Type, 2011-2022 (USD Million)
Table Application Segment of Bio-pharma
Table Metabolic Disorders Overview
Table Oncology Overview
Table Neurological Disorders Overview
Table Cardiovascular Diseases Overview
Table Inflammatory and Infectious Diseases Overview
Table Others Overview
Table Global Bio-pharma Market by Application, 2011-2022 (USD Million)
Table Global Bio-pharma Market by Region, 2011-2022 (USD Million)
Table Cost of Bio-pharma
Table Market Dynamics
Table Policy of Bio-pharma
Table GDP of Major Countries
Table Monoclonal Antibodies CAGR by Revenue and Volume, 2012-2018
Table Recombinant Proteins CAGR by Revenue and Volume, 2012-2018
Table Granulocyte-Colony Stimulating Factor (G-CSF) CAGR by Revenue and Volume, 2012-2018
Table Interferons CAGR by Revenue and Volume, 2012-2018
Table Recombinant Human Insulin CAGR by Revenue and Volume, 2012-2018
Table Erythropoietin CAGR by Revenue and Volume, 2012-2018
Table Vaccines CAGR by Revenue and Volume, 2012-2018
Table Growth Hormones CAGR by Revenue and Volume, 2012-2018
Table Purified Proteins CAGR by Revenue and Volume, 2012-2018
Table Others CAGR by Revenue and Volume, 2012-2018
Table Monoclonal Antibodies CAGR by Revenue and Volume, 2012-2024
Table Recombinant Proteins CAGR by Revenue and Volume, 2012-2024
Table Granulocyte-Colony Stimulating Factor (G-CSF) CAGR by Revenue and Volume, 2012-2024
Table Interferons CAGR by Revenue and Volume, 2012-2024
Table Recombinant Human Insulin CAGR by Revenue and Volume, 2012-2024
Table Erythropoietin CAGR by Revenue and Volume, 2012-2024
Table Vaccines CAGR by Revenue and Volume, 2012-2024
Table Growth Hormones CAGR by Revenue and Volume, 2012-2024
Table Purified Proteins CAGR by Revenue and Volume, 2012-2024
Table Others CAGR by Revenue and Volume, 2012-2024
Table Metabolic Disorders CAGR by Revenue and Volume, 2012-2018
Table Oncology CAGR by Revenue and Volume, 2012-2018
Table Neurological Disorders CAGR by Revenue and Volume, 2012-2018
Table Cardiovascular Diseases CAGR by Revenue and Volume, 2012-2018
Table Inflammatory and Infectious Diseases CAGR by Revenue and Volume, 2012-2018
Table Others CAGR by Revenue and Volume, 2012-2018
Table Global Bio-pharma Market by Vendors, 2012-2018 (USD Million)
Table Global Bio-pharma Market by Vendors, 2012-2018 (in Volume)
Table Global Bio-pharma Market Share by Vendors, 2012-2018 (USD Million)
Table Global Bio-pharma Market Share by Vendors, 2012-2018 (in Volume)
Table Price Factors List
Table Pfizer Profile List
Table Microecological Modulator Operating Data of Pfizer (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table F. Hoffmann-La Roche AG Profile List
Table Microecological Modulator Operating Data of F. Hoffmann-La Roche AG (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Johnson & Johnson Services Profile List
Table Microecological Modulator Operating Data of Johnson & Johnson Services (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Sanofi, Amgen Profile List
Table Microecological Modulator Operating Data of Sanofi, Amgen (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table AbbVie Profile List
Table Microecological Modulator Operating Data of AbbVie (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Merck & Co. Profile List
Table Microecological Modulator Operating Data of Merck & Co. (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Biogen Idec Profile List
Table Microecological Modulator Operating Data of Biogen Idec (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Bayer AG Profile List
Table Microecological Modulator Operating Data of Bayer AG (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Eli Lilly and Company Profile List
Table Microecological Modulator Operating Data of Eli Lilly and Company (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Novartis AG GlaxoSmithKline Plc Profile List
Table Microecological Modulator Operating Data of Novartis AG GlaxoSmithKline Plc (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Bristol-Myers Squibb Company Profile List
Table Microecological Modulator Operating Data of Bristol-Myers Squibb Company (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table AstraZeneca PLC Profile List
Table Microecological Modulator Operating Data of AstraZeneca PLC (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Abbott Laboratories Profile List
Table Microecological Modulator Operating Data of Abbott Laboratories (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

List Of Figures

LIST OF FIGURES

Figure Bio-pharma Picture
Figure Industry Chain Structure of Bio-pharma
Figure SWOT of Bio-pharma
Figure Monoclonal Antibodies Market Size and Growth, 2012-2018 (USD Million)
Figure Monoclonal Antibodies Market Size and Growth, 2012-2018 (in Volume)
Figure Recombinant Proteins Market Size and Growth, 2012-2018 (USD Million)
Figure Recombinant Proteins Market Size and Growth, 2012-2018 (in Volume)
Figure Granulocyte-Colony Stimulating Factor (G-CSF) Market Size and Growth, 2012-2018 (USD Million)
Figure Granulocyte-Colony Stimulating Factor (G-CSF) Market Size and Growth, 2012-2018 (in Volume)
Figure Interferons Market Size and Growth, 2012-2018 (USD Million)
Figure Interferons Market Size and Growth, 2012-2018 (in Volume)
Figure Recombinant Human Insulin Market Size and Growth, 2012-2018 (USD Million)
Figure Recombinant Human Insulin Market Size and Growth, 2012-2018 (in Volume)
Figure Erythropoietin Market Size and Growth, 2012-2018 (USD Million)
Figure Erythropoietin Market Size and Growth, 2012-2018 (in Volume)
Figure Vaccines Market Size and Growth, 2012-2018 (USD Million)
Figure Vaccines Market Size and Growth, 2012-2018 (in Volume)
Figure Growth Hormones Market Size and Growth, 2012-2018 (USD Million)
Figure Growth Hormones Market Size and Growth, 2012-2018 (in Volume)
Figure Purified Proteins Market Size and Growth, 2012-2018 (USD Million)
Figure Purified Proteins Market Size and Growth, 2012-2018 (in Volume)
Figure Others Market Size and Growth, 2012-2018 (USD Million)
Figure Others Market Size and Growth, 2012-2018 (in Volume)
Figure Monoclonal Antibodies Market Estimates and Forecasts, 2019-2024 (USD Million)
Figure Monoclonal Antibodies Market Estimates and Forecasts, 2019-2024 (in Volume)
Figure Recombinant Proteins Market Estimates and Forecasts, 2019-2024 (USD Million)
Figure Recombinant Proteins Market Estimates and Forecasts, 2019-2024 (in Volume)
Figure Granulocyte-Colony Stimulating Factor (G-CSF) Market Estimates and Forecasts, 2019-2024 (USD Million)
Figure Granulocyte-Colony Stimulating Factor (G-CSF) Market Estimates and Forecasts, 2019-2024 (in Volume)
Figure Interferons Market Estimates and Forecasts, 2019-2024 (USD Million)
Figure Interferons Market Estimates and Forecasts, 2019-2024 (in Volume)
Figure Recombinant Human Insulin Market Estimates and Forecasts, 2019-2024 (USD Million)
Figure Recombinant Human Insulin Market Estimates and Forecasts, 2019-2024 (in Volume)
Figure Erythropoietin Market Estimates and Forecasts, 2019-2024 (USD Million)
Figure Erythropoietin Market Estimates and Forecasts, 2019-2024 (in Volume)
Figure Vaccines Market Estimates and Forecasts, 2019-2024 (USD Million)
Figure Vaccines Market Estimates and Forecasts, 2019-2024 (in Volume)
Figure Growth Hormones Market Estimates and Forecasts, 2019-2024 (USD Million)
Figure Growth Hormones Market Estimates and Forecasts, 2019-2024 (in Volume)
Figure Purified Proteins Market Estimates and Forecasts, 2019-2024 (USD Million)
Figure Purified Proteins Market Estimates and Forecasts, 2019-2024 (in Volume)
Figure Others Market Estimates and Forecasts, 2019-2024 (USD Million)
Figure Others Market Estimates and Forecasts, 2019-2024 (in Volume)
Figure Metabolic Disorders Market Size and Growth, 2012-2018 (USD Million)
Figure Market Size and Growth, 2012-2018 (in Volume)
Figure Oncology Market Size and Growth, 2012-2018 (USD Million)
Figure Market Size and Growth, 2012-2018 (in Volume)
Figure Neurological Disorders Market Size and Growth, 2012-2018 (USD Million)
Figure Market Size and Growth, 2012-2018 (in Volume)
Figure Cardiovascular Diseases Market Size and Growth, 2012-2018 (USD Million)
Figure Market Size and Growth, 2012-2018 (in Volume)
Figure Inflammatory and Infectious Diseases Market Size and Growth, 2012-2018 (USD Million)
Figure Market Size and Growth, 2012-2018 (in Volume)
Figure Others Market Size and Growth, 2012-2018 (USD Million)
Figure Market Size and Growth, 2012-2018 (in Volume)
Figure Asia-Pacific Market Size and Growth, 2012-2018 (USD Million)
Figure Asia-Pacific Market Size and Growth, 2012-2018 (in Volume)
Figure Asia-Pacific Market Size by Type
Figure Asia-Pacific Market Share by Type
Figure Asia-Pacific Market Size by Application
Figure Asia-Pacific Market Share by Application
Figure North America Market Size and Growth, 2012-2018 (USD Million)
Figure North America Market Size and Growth, 2012-2018 (in Volume)
Figure North America Market Size by Type
Figure North America Market Share by Type
Figure North America Market Size by Application
Figure North America Market Share by Application
Figure Europe Market Size and Growth, 2012-2018 (USD Million)
Figure Europe Market Size and Growth, 2012-2018 (in Volume)
Figure Europe Market Size by Type
Figure Europe Market Share by Type
Figure Europe Market Size by Application
Figure Europe Market Share by Application
Figure South America Market Size and Growth, 2012-2018 (USD Million)
Figure South America Market Size and Growth, 2012-2018 (in Volume)
Figure South America Market Size by Type
Figure South America Market Share by Type
Figure South America Market Size by Application
Figure South America Market Share by Application
Figure Middle East & Africa Market Size and Growth, 2012-2018 (USD Million)
Figure Middle East & Africa Market Size and Growth, 2012-2018 (in Volume)
Figure Middle East & Africa Market Size by Type
Figure Middle East & Africa Market Share by Type
Figure Middle East & Africa Market Size by Application
Figure Middle East & Africa Market Share by Application
Figure Asia-Pacific Market Estimates and Forecasts, 2019-2024 (USD Million)
Figure Asia-Pacific Market Estimates and Forecasts, 2019-2024 (in Volume)
Figure North America Market Estimates and Forecasts, 2019-2024 (USD Million)
Figure North America Market Estimates and Forecasts, 2019-2024 (in Volume)
Figure Europe Market Estimates and Forecasts, 2019-2024 (USD Million)
Figure Europe Market Estimates and Forecasts, 2019-2024 (in Volume)
Figure South America Market Estimates and Forecasts, 2019-2024 (USD Million)
Figure South America Market Estimates and Forecasts, 2019-2024 (in Volume)
Figure Middle East & Africa Market Estimates and Forecasts, 2019-2024 (USD Million)
Figure Middle East & Africa Market Estimates and Forecasts, 2019-2024 (in Volume)
Figure Bio-pharma Market Concentration by Region
Figure Marketing Channels Overview